Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,431 shares at $645.08 ($2.9M) on 2021-11-17, disclosed to the SEC on 2021-11-18.
Open-market sale of $2.9M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $651.97 | 3,069 | $2.0M | 69.5% |
| 2 | $645.08 | 681 | $439K | 15.3% |
| 3 | $645.08 | 681 | $439K | 15.3% |
| Total | $649.85 avg | 4,431 | $2.9M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |